Category Pharmaceuticals

Psychedelics, Doing Science, and Policing History

Erika Dyck describes how the recent surge in psychedelic research presents opportunities to rethink how we do science, and how we measure the impact of science.

Marijuana Tax: where will the money go when we legalize?

Chelsea Cox explores the financial and ethical implications of Canada’s upcoming legalization of marijuana.

The Opioid Epidemic is an Epidemic of Stigma

Kristie Serota and Daniel Z. Buchman argue that eradicating the stigma associated with opioid use is an ethical necessity and is critical for population health.

Access to Physicians’ Prescription Habits

Jean-Christophe Bélisle-Pipon calls attention to issues of accessibility and transparency related to the collection and sale of physician prescribing data by data solution companies.

Four Reasons Canada Needs Universal Pharmacare

Steve Morgan gives us four reasons to support universal pharmacare and then invites us to sign the Parliamentary Petition e-959 (Health care services).

Expert Advisory Committees & Conflict of Interest

Jean-Christophe Bélisle-Pipon, Louise Ringuette, and Bryn Williams-Jones describe a five-step approach for managing conflicts of interest in public health decision-making.

Using Social Media to Sell Prescription Drugs

Jean-Christophe Bélisle-Pipon and Stanislav Birko consider how direct-to-consumer marketing of prescription drugs using social media might be prevented by amending Canada’s Food and Drug Regulations.